News and Trends 1 May 2019
Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma
Cell Medica’s next-generation CAR-T cell therapy has resulted in 'extensive tumor regression' in a child with high-risk neuroblastoma, one…
Cell Medica
- Latest Posts
News and Trends 27 Feb 2019
UK Biotech Gets Huge Grant to Launch Off-the-Shelf CAR-T Cancer Therapy to Clinic
The UK biotech Cell Medica has received a €7.6M ($8.7M) grant from the Cancer Prevention and Research Institute of Texas…
Best in Biotech 20 Feb 2018
Money, Money, Money! Europe’s Best-Funded Biotechs in 2018
Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where many of us re-examine our…
News and Trends 21 Jun 2017
British Biotech Tops up its Cancer Pipeline with New TCR Therapy
Cell Medica just acquired Catapult Therapy TCR, set up by UK's CGT Catapult, gaining the rights to its TCR therapy…
ADVERTISEMENT
News and Trends 16 Mar 2017
UK Immunotherapy Biotech raises Massive Funding in Series C
The UK biotech Cell Medica picked up a massive €69M (£60M) in its recent Series C funding round to advance its…
News and Trends 21 Feb 2017
New Immunotherapy Candidate receives FDA Fast Track Designation
Cell Medica's Orphan Drug CMD-003 has received fast track designation by the FDA to advance immunotherapy of patients with Epstein Bar Virus…